Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Abata hires Leonard Dragone as CMO

Plus: Amylyx gets a head of international markets, and updates from Heron, Breye, Alvotech and more

April 20, 2023 7:43 PM UTC

Regulatory T cell therapy company Abata Therapeutics Inc. hired Leonard Dragone as CMO, to succeed co-founder and interim CMO Richard Ransohoff. Dragone was CMO at Sonoma Biotherapeutics Inc.; Ransohoff, who will become an adviser to the company, is a venture partner at Third Rock Ventures. 

Neurodegenerative disease company Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) hired Masako Nakamura as general manager and head of international markets — Asia Pacific and Latin America. Nakamura was SVP, head of Asia at Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and held various roles during her decade at the Genzyme Corp. unit of Sanofi (Euronext:SAN; NASDAQ:SNY). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article